Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Islet Studies

Stress-Induced MicroRNA-708 Impairs β-Cell Function and Growth

  1. Júlia Rodríguez-Comas1,
  2. Alba Moreno-Asso1,2,
  3. Juan Moreno-Vedia1,
  4. Mercè Martín1,
  5. Carlos Castaño1,2,
  6. Anna Marzà-Florensa1,
  7. Xavier Bofill-De Ros3,4,
  8. Joan Mir-Coll1,5,
  9. Joel Montané1,2,
  10. Cristina Fillat3,4,
  11. Rosa Gasa1,2,
  12. Anna Novials1,2⇑ and
  13. Joan-Marc Servitja1,2⇑
  1. 1Diabetes and Obesity Research Laboratory, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
  2. 2Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas (CIBERDEM), Barcelona, Spain
  3. 3Gene Therapy and Cancer Laboratory, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
  4. 4Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain
  5. 5Department of Medicine, University of Barcelona, Barcelona, Spain
  1. Corresponding authors: Anna Novials, anovials{at}clinic.cat, or
  2. Joan-Marc Servitja, servitja{at}clinic.cat.
  1. J.R.-C. and A.M.-A. contributed equally to this study.

Diabetes 2017 Dec; 66(12): 3029-3040. https://doi.org/10.2337/db16-1569
PreviousNext
  • Article
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    miR-708, Odz4, and Chop are upregulated in islets cultured at low glucose concentrations. A–C: Glucose regulation pattern of the three most upregulated miRNAs at G3 with respect to G11. Quantitative RT-PCR analysis of miR-708 (A), miR-451a (B), and miR-339-5p (C) in islets cultured for 2.5 days at indicated glucose concentrations (G3, G5, G11, and G25). Glucose regulation pattern of Odz4 (D) and Chop (E) in islets cultured at the indicated glucose concentrations for 2.5 days. Time course of Chop (F), Odz4 (G), and miR-708 (H) expression in pancreatic islets exposed to a low glucose concentration (G3). Gene expression data were normalized against Hprt1, and miRNAs were normalized against Let7i, RNU1A1, and RNU5G and are shown relative to levels at G11, which were set arbitrarily to 1. Results are expressed as the mean ± SEM from at least three independent experiments (n = 7–15). *P < 0.05; **P < 0.01; ***P < 0.001.

  • Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2

    ER stress induces miR-708 activation. Expression of Chop (A), Odz4 (B), and miR-708 (C) was quantified by quantitative RT-PCR in pancreatic islets cultured at G11 and treated with 1 µmol/L Thp for 24 h. D and E: Chop was knocked down using siRNA (i.e., siChop; 20 µmol/L) in INS1E cells cultured at G11. Twenty-four hours after transfection, cells were treated with 1 µmol/L Thp for 24 h and the expression of Chop (D) and miR-708 (E) was analyzed. Scrambled (Scrbl) siRNA was used as a control (Thp Scrbl). F–H: Chop, Odz4, and miR-708 expression in islets cultured at G11 or G25 for 2.5 days or 1 week. I–K: PBA ameliorates the stress response in islets cultured at low glucose levels. Chop, Odz4, and miR-708 expression in islets cultured at the indicated glucose concentrations and were treated (PBA) or not (Con) with 2.5 mmol/L PBA for 2.5 days. Results are expressed as the mean ± SEM from three independent experiments (n = 7–12). *P < 0.05, **P < 0.01, ***P < 0.001; #P < 0.05, ##P < 0.01, ###P < 0.001 comparing PBA treatment (white bar) with its respective control at the same glucose concentration (black bar).

  • Figure 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3

    miR-708 overexpression reduces Nnat levels. Nnat expression in islets (A) and DICs (B) transduced with AdmiR-708 (20 MOI) or AdGFP (20 MOI), or nontransduced (Con). C: Representative immunoblot of Nnat in MIN6 transduced with AdmiR-708 (20 MOI) or AdGFP (20 MOI), or nontransduced (control). Scatter plots show mean and SD of the quantification of the Western blot bands for Nnat normalized to β-actin (n = 3). D: Glucose regulation pattern of Nnat in islets cultured at G3, G5, and G11 not treated (Con) or treated with PBA (2.5 mmol/L) for 2.5 days. E: Nnat expression in islets cultured at G11 in the presence or absence of 1 µmol/L Thp. F: Transfection of siChop (20 μmol/L) in INS1E cells treated with 1 µmol/L Thp leads to increases in mRNA levels of Nnat. Scrambled (Scrbl) siRNA was used as a control. Gene expression data were normalized against Hprt1 and are shown relative to levels at G11, which were set arbitrarily to 1. A, B, and D–F: Results are expressed as the mean ± SEM from three or more independent experiments (n = 7–12). *P < 0.05, **P < 0.01, ***P < 0.001; ###P < 0.001 comparing PBA treatment (white bars) with its respective control at the same glucose concentration (black bars).

  • Figure 4
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4

    miR-708 expression is increased in ob/ob mice islets. Islets from 14-week-old male ob/ob mice (open circles) and heterozygous male littermates (ob/+, black circles) were isolated. Expression levels of miR-708 (A), miR-375 (B), Odz4 (C), Nnat (D), Pdx1 (E), Chop (F), Xbp1s (G), Atf6 (H), and Atf3 (I) were analyzed. Results are expressed as the mean and SD of four mice per group. *P < 0.05, **P < 0.01.

  • Figure 5
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5

    miR-708 overexpression reduces insulin secretion. A: GSIS assays were performed in islets cultured for 2.5 days at G11 that were nontransduced (Control) or transduced with AdGFP or AdmiR-708 (20 MOI). For the GSIS assays, islets were incubated for 1 h at 2.8 mmol/L glucose or at 16.7 mmol/L glucose. B: Total insulin content (normalized by protein content) present in islets after the GSIS assay shown in A. C: GSIS assays were performed in nontreated islets (Con, control) or islets treated with a negative control miRNA (Neg. Ctrl.; 500 nmol/L) or an inhibitor of miR-708 (αmiR-708; 500 nmol/L) during a 2.5-day culture at G5 or G11. D: Total insulin content (normalized by protein content) present in islets after the GSIS assay shown in C. E: GSIS assays of islets cultured for 2.5 days at G11 and transduced with AdmiR-708 (20 MOI), AdNnat (5 MOI), and both together. Results are expressed as mean ± SEM from three independent experiments, each one including at least three different replicates per condition. *P < 0.05, **P < 0.01, ***P < 0.001; #P < 0.05, ###P < 0.001 compared with its respective control (Con) at G11.

  • Figure 6
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6

    miR-708 overexpression represses β-cell proliferation and induces β-cell apoptosis. A: Representative images of insulin immunostaining (red) of DICs cultured at G11 for 72 h that were nontransduced (G11), were transduced with AdGFP (G11+AdGFP), or were transduced with AdmiR-708 (G11+AdmiR-708). Scale bar = 400 µm. B: Quantification of the insulin-positive area of DICs treated as in A. Data are shown relative to control samples (G11), which were arbitrarily set to 1. C: Insulin-positive area of DICs cultured at G3, G5, G11, G16 (16.7 mmol/L glucose), and at G11 in the presence of 1 µmol/L Thp. Data are shown relative to levels at G11. Note that the reduction of β-cell growth at G3 and in Thp-treated cells is similar to that observed in miR-708–overexpressing cells. D: Percentage of Ki67-positive β-cells with respect to the total number of β-cells in DICs cultured for 72 h at the indicated glucose concentrations and at G11 and transduced with AdGFP or AdmiR-708 (20 MOI). E: Insulin-positive area of DICs cultured at G5 or G11 for 72 h that were nontreated (Con, control) or treated with a negative control miRNA (Neg. Ctrl.; 500 nmol/L) or an inhibitor of miR-708 (αmiR-708; 500 nmol/L). ***P < 0.001 compared with its corresponding G11 condition. F: DICs cultured for 72 h at G5 and G11 were nontransduced or transduced with AdmiR-708 (20 MOI), AdNnat (5 MOI), and both together. G: Representative images of TUNEL (green), Hoechst (blue), and insulin (red) staining of pancreatic islets. Islets were not transduced (G11) or were transduced with AdGFP or AdmiR-708 (20 MOI). Arrows point to apoptotic cells identified by TUNEL staining. H: Quantification of β-cell apoptosis calculated as the percentage of TUNEL-positive β-cells with respect to the total number of insulin-positive cells. Results are expressed as the mean ± SEM from at least three independent experiments (n = 7–14). **P < 0.01, ***P < 0.001; ##P < 0.01, ###P < 0.001 compared with the control G11 condition.

Tables

  • Figures
  • Table 1

    Glucose-regulated miRNAs in mouse pancreatic islets

    Fold changeP valueCt G3Ct G11
    Upregulated miRNAs at low glucose (G3 vs. G11)
     mmu-miR-708-5p6.70.001429.0 ± 0.1331.9 ± 0.39
     mmu-miR-339-5p2.50.003231.8 ± 0.5033.1 ± 0.30
     mmu-miR-451a2.50.037734.0 ± 0.0634.5 ± 0.39
     mmu-miR-224-5p2.10.043334.2 ± 0.2035.4 ± 0.29
     mmu-miR-129-2-3p2.00.006228.7 ± 0.4830.0 ± 0.05
     mmu-miR-467a-5p1.90.032331.8 ± 0.2533.0 ± 0.27
     mmu-miR-151-3p1.90.025030.1 ± 0.0531.3 ± 0.06
    Downregulated miRNAs at low glucose (G3 vs. G11)
     rno-miR-346−3.20.001733.9 ± 0.2832.5 ± 0.15
     mmu-miR-138-5p−2.50.030035.0 ± 0.2034.0 ± 0.32
     mmu-miR-33-5p−2.10.024629.7 ± 0.7728.7 ± 0.12
     mmu-miR-541-5p−1.80.029728.9 ± 0.3928.3 ± 0.10
     mmu-miR-370-3p−1.60.011830.8 ± 0.3930.3 ± 0.08
    • The expression of miRNAs was analyzed by a high-throughput screening of miRNA expression using quantitative PCR 384-well panels. RNA was extracted from mouse pancreatic islets cultured at 2.8 mmol/L glucose (G3) and at 11.1 mmol/L glucose (G11) for 2.5 days. Ct G3 and Ct G11 values indicate the cycle threshold ± SEM from qPCR analysis. cDNA synthesis for each sample was performed using 20 ng of total RNA. The listed miRNAs are those whose expression is significantly different between the G3 and G11 conditions. Statistical significance was determined by multiple t tests corrected for multiple comparisons using the Holm-Sidak method (P < 0.05).

PreviousNext
Back to top
Diabetes: 66 (12)

In this Issue

December 2017, 66(12)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Stress-Induced MicroRNA-708 Impairs β-Cell Function and Growth
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Stress-Induced MicroRNA-708 Impairs β-Cell Function and Growth
Júlia Rodríguez-Comas, Alba Moreno-Asso, Juan Moreno-Vedia, Mercè Martín, Carlos Castaño, Anna Marzà-Florensa, Xavier Bofill-De Ros, Joan Mir-Coll, Joel Montané, Cristina Fillat, Rosa Gasa, Anna Novials, Joan-Marc Servitja
Diabetes Dec 2017, 66 (12) 3029-3040; DOI: 10.2337/db16-1569

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Stress-Induced MicroRNA-708 Impairs β-Cell Function and Growth
Júlia Rodríguez-Comas, Alba Moreno-Asso, Juan Moreno-Vedia, Mercè Martín, Carlos Castaño, Anna Marzà-Florensa, Xavier Bofill-De Ros, Joan Mir-Coll, Joel Montané, Cristina Fillat, Rosa Gasa, Anna Novials, Joan-Marc Servitja
Diabetes Dec 2017, 66 (12) 3029-3040; DOI: 10.2337/db16-1569
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Research Design and Methods
    • Results
    • Discussion
    • Article Information
    • Footnotes
    • References
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Pancreatic β-Cell–Specific Deletion of VPS41 Causes Diabetes Due to Defects in Insulin Secretion
  • Retinol-Binding Protein 4 Activates STRA6, Provoking Pancreatic β-Cell Dysfunction in Type 2 Diabetes
  • Loss of Furin in β-Cells Induces an mTORC1-ATF4 Anabolic Pathway That Leads to β-Cell Dysfunction
Show more Islet Studies

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.